The potential RNAi-based combination therapeutics
Arch Pharm Res
.
2011 Jan;34(1):1-2.
doi: 10.1007/s12272-011-0100-9.
Authors
Hun Soon Jung
1
,
Young Kee Shin
Affiliation
1
Laboratory of Molecular Pathology and Cancer Genomics, Department of Pharmacy, College of Pharmacy, Seoul National University, Korea.
PMID:
21468909
DOI:
10.1007/s12272-011-0100-9
No abstract available
Publication types
Comment
MeSH terms
Cell Line, Tumor
Combined Modality Therapy
Humans
Neoplasms / genetics
Neoplasms / therapy*
RNA Interference*
RNA, Small Interfering / therapeutic use*
Substances
RNA, Small Interfering